Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Orbital Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Cambridge, Massachusetts, United States Founded 2022 51-100 employees For Profit

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Orbital Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Orbital Therapeutics was acquired by Bristol-Myers Squibb in 2025 for $1.5B.
Total Funding
$270M
Funding Rounds
2
Last Funding
Acquisitions
0
Monthly Visits
Contacts
50

About Orbital Therapeutics

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
6
IT spend
$652.29K

Company Info

Founded
2022
Employees
51-100
Operating status
Active
Company type
For Profit
Org types
company
Founders
8
News articles
90
HQ
Cambridge, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England
Diversity spotlight
Women Founded
Exit date
Oct 10, 2025

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
-0.2
Trend (90d)
-1.8
Last leadership hire
Sep 4, 2025

Orbital Therapeutics Funding Rounds

2 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesOrg Hq Country
1–2 of 2Show
Page 1 / 1

Orbital Therapeutics Key People

Senior Vice President, Clinical Development
CEO & Board of Directors
50
professional contacts at Orbital Therapeutics
Contact execs at Orbital Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

FAQs about Orbital Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.